Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast Cancer
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07643831. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label Expanded Access Program to Provide Giredestrant to Patients With ER+, HER2- Early or Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this expanded access program (EAP) is to provide early access to giredestrant for participants with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (eBC) or locally advanced/metastatic breast cancer (LA/mBC) prior to commercial availability in the United States.
Study identification
- NCT ID
- NCT07643831
- Recruitment status
- Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Nov 10, 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Oncology and Hematology | Anchorage | Alaska | 99508-2959 | Available |
| Community Cancer Institute (CCI) | Clovis | California | 93611-6878 | Available |
| Orange Coast Medical Center | Fountain Valley | California | 92708-6728 | Available |
| Redlands Oncology Center for Cancer Care | Redlands | California | 92373 | Available |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010-3017 | Available |
| Lynn Cancer Institute | Boca Raton | Florida | 33486-2305 | Available |
| New England Cancer Specialists - Westbrook | Westbrook | Maine | 04092 | Available |
| University of Michigan Health-West | Wyoming | Michigan | 49519 | Available |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901-1914 | Available |
| San Juan Oncology Associates - Four Corners Cancer Center | Farmington | New Mexico | 87401-8900 | Available |
| Good Samaritan Medical Center - Oregon | Corvallis | Oregon | 97330 | Available |
| Northwest Medical Specialties (Tacoma) | Tacoma | Washington | 98405-5016 | Available |
| West Virginia University (WVU) - WVU Cancer Institute | Morgantown | West Virginia | 26506-1200 | Available |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07643831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2026 · Synced Nov 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.